Neuland Laboratories Limited
NSE: NEULANDLAB.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Davuluri Saharsh Rao
- Employees
- 1,643
- Headquarters
- Hyderabad, India
- IPO year
- 2008
- Market cap
- ₹226.7B
- Website
- https://www.neulandlabs.com
Loading NEULANDLAB…
Loading profile data…Frequently asked questions about NEULANDLAB
What does Neuland Laboratories Limited (NEULANDLAB.NS) do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacte...
Where does NEULANDLAB.NS trade?
Neuland Laboratories Limited (NEULANDLAB.NS) trades on the National Stock Exchange of India.
What sector is NEULANDLAB.NS in?
Neuland Laboratories Limited (NEULANDLAB.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Neuland Laboratories Limited?
Davuluri Saharsh Rao is the chief executive officer of Neuland Laboratories Limited (NEULANDLAB.NS).
Where is Neuland Laboratories Limited headquartered?
Neuland Laboratories Limited is headquartered in India.
Does NEULANDLAB.NS pay a dividend?
Yes — Neuland Laboratories Limited (NEULANDLAB.NS) paid a trailing twelve-month dividend of INR 12.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did NEULANDLAB.NS go public?
Neuland Laboratories Limited (NEULANDLAB.NS) completed its initial public offering in 2008.